{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T19:48:57Z","timestamp":1791575337909,"version":"4.3.4"},"reference-count":92,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1007\/s00296-021-04987-0","type":"journal-article","created":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T07:12:42Z","timestamp":1633072362000},"page":"2091-2103","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["COVID-19 from a rheumatology perspective: bibliometric and altmetric analysis"],"prefix":"10.1007","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1650-8928","authenticated-orcid":false,"given":"Bohdana","family":"Doskaliuk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1262-5609","authenticated-orcid":false,"given":"Roman","family":"Yatsyshyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6616-1980","authenticated-orcid":false,"given":"Iryna","family":"Klishch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4188-8486","authenticated-orcid":false,"given":"Olena","family":"Zimba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,1]]},"reference":[{"issue":"6","key":"4987_CR1","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1056\/NEJMp2008017","volume":"383","author":"B Pfefferbaum","year":"2020","unstructured":"Pfefferbaum B, North CS (2020) Mental health and the COVID-19 pandemic. N Engl J Med 383(6):510\u2013512. https:\/\/doi.org\/10.1056\/NEJMp2008017","journal-title":"N Engl J Med"},{"issue":"27","key":"4987_CR2","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2020.35.e256","volume":"35","author":"L Gupta","year":"2020","unstructured":"Gupta L, Gasparyan AY, Misra DP, Agarwal V, Zimba O, Yessirkepov M (2020) Information and misinformation on COVID-19: a cross-sectional survey study. J Korean Med Sci 35(27):e256. https:\/\/doi.org\/10.3346\/jkms.2020.35.e256","journal-title":"J Korean Med Sci"},{"issue":"4","key":"4987_CR3","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1007\/s00296-020-04714-1","volume":"41","author":"A Akyol","year":"2021","unstructured":"Akyol A, Kocyigit BF (2021) Publication activity in the field of Sj\u00f6gren\u2019s syndrome: a ten-year Web of Science-based analysis. Rheumatol Int 41(4):763\u2013769. https:\/\/doi.org\/10.1007\/s00296-020-04714-1","journal-title":"Rheumatol Int"},{"key":"4987_CR4","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-021-04836-0","author":"A Akyol","year":"2021","unstructured":"Akyol A, Kocyigit BF (2021) Ankylosing spondylitis rehabilitation publications and the global productivity: a Web of Science-based bibliometric analysis (2000\u20132019). Rheumatol Int. https:\/\/doi.org\/10.1007\/s00296-021-04836-0","journal-title":"Rheumatol Int"},{"issue":"21","key":"4987_CR5","first-page":"3374","volume":"25","author":"W Ren","year":"2021","unstructured":"Ren W, Liao Y (2021) Visualization analysis of traumatic osteoarthritis research hotspots and content based on CiteSpace. Chin J Tissue Eng Res 25(21):3374","journal-title":"Chin J Tissue Eng Res"},{"key":"4987_CR6","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-021-04852-0","author":"D El Masri","year":"2021","unstructured":"El Masri D, Alsaayed B, El Masri J, Zreika B, Chanbour H, Salameh P (2021) Contribution of Arab countries to familial mediterranean fever research: a pubmed-based bibliometric analysis. Rheumatol Int. https:\/\/doi.org\/10.1007\/s00296-021-04852-0","journal-title":"Rheumatol Int"},{"issue":"1","key":"4987_CR7","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1136\/annrheumdis-2020-219217","volume":"80","author":"K Lauper","year":"2021","unstructured":"Lauper K, Bijlsma JW, Burmester GR (2021) Trajectories of COVID-19 information in the Annals of the rheumatic diseases: the first months of the pandemic. Ann Rheum Dis 80(1):26\u201330. https:\/\/doi.org\/10.1136\/annrheumdis-2020-219217","journal-title":"Ann Rheum Dis"},{"key":"4987_CR8","unstructured":"(2021) https:\/\/www.elsevier.com\/__data\/assets\/pdf_file\/0017\/114533\/Scopus_GlobalResearch_Factsheet2019_FINAL_WEB.pdf. Accessed 26 Jul 2021"},{"key":"4987_CR9","doi-asserted-by":"publisher","DOI":"10.3791\/58494","volume":"152","author":"SAS AlRyalat","year":"2019","unstructured":"AlRyalat SAS, Malkawi LW, Momani SM (2019) Comparing bibliometric analysis using PubMed, Scopus, and Web of Science databases. JoVE 152:e58494. https:\/\/doi.org\/10.3791\/58494","journal-title":"JoVE"},{"issue":"4","key":"4987_CR10","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1016\/j.joi.2016.10.006","volume":"10","author":"A Perianes-Rodriguez","year":"2016","unstructured":"Perianes-Rodriguez A, Waltman L, Van Eck NJ (2016) Constructing bibliometric networks: a comparison between full and fractional counting. J Informetrics 10(4):1178\u20131195. https:\/\/doi.org\/10.1016\/j.joi.2016.10.006","journal-title":"J Informetrics"},{"issue":"7","key":"4987_CR11","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1136\/annrheumdis-2020-217871","volume":"79","author":"M Gianfrancesco","year":"2020","unstructured":"Gianfrancesco M, Hyrich KL, Al-Adely S, Carmona L, Danila MI, Gossec L, Izadi Z, Jacobsohn L, Katz P, Lawson-Tovey S, Mateus EF (2020) Characteristics associated with hospitalization for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry. Ann Rheum Dis 79(7):859\u2013866","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"4987_CR12","doi-asserted-by":"publisher","first-page":"e437","DOI":"10.1016\/S2665-9913(20)30121-1","volume":"2","author":"D McGonagle","year":"2020","unstructured":"McGonagle D, O\u2019Donnell JS, Sharif K, Emery P, Bridgewood C (2020) Immune mechanisms of pulmonary intravascular coagulopathy in COVID-19 pneumonia. Lancet Rheumatol 2(7):e437\u2013e445","journal-title":"Lancet Rheumatol"},{"issue":"SI-1","key":"4987_CR13","doi-asserted-by":"publisher","first-page":"620","DOI":"10.3906\/sag-2004-168","volume":"50","author":"A Tufan","year":"2020","unstructured":"Tufan A, G\u00fcler AA, Matucci-Cerinic M (2020) COVID-19, immune system response, hyperinflammation and repurposing antirheumatic drugs. Turk J Med Sci 50(SI-1):620\u2013632","journal-title":"Turk J Med Sci"},{"issue":"5","key":"4987_CR14","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/j.semarthrit.2020.07.012","volume":"50","author":"SO Ho","year":"2020","unstructured":"Ho SO, Mak JW, Jacqueline SO, Grace LU, Frankie LU, Jolly LE, Shirley CH, Carmen HO, Chan JM, Shing-Pak KO, Woon-Leung NG (2020) Incidence and clinical course of COVID-19 in patients with rheumatologic diseases: a population-based study. Semin Arthritis Rheum 50(5):885\u2013889. https:\/\/doi.org\/10.1016\/j.semarthrit.2020.07.012","journal-title":"Semin Arthritis Rheum"},{"issue":"9","key":"4987_CR15","doi-asserted-by":"publisher","first-page":"e549","DOI":"10.1016\/S2665-9913(20)30169-7","volume":"2","author":"M Fredi","year":"2020","unstructured":"Fredi M, Cavazzana I, Moschetti L et al (2020) COVID-19 in patients with rheumatic diseases in northern Italy: a single-center observational and case-control study. Lancet Rheumatol 2(9):e549\u2013e556. https:\/\/doi.org\/10.1016\/S2665-9913(20)30169-7","journal-title":"Lancet Rheumatol"},{"key":"4987_CR16","doi-asserted-by":"publisher","first-page":"e93","DOI":"10.1016\/j.jinf.2020.05.065","volume":"81","author":"M Liu","year":"2020","unstructured":"Liu M, Gao Y, Zhang Y, Shi S, Chen Y, Tian J (2020) The association between severe or death COVID-19 and autoimmune disease: a systematic review and meta-analysis. J Infect 81:e93-95","journal-title":"J Infect"},{"issue":"2","key":"4987_CR17","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1136\/annrheumdis-2020-217615","volume":"80","author":"EG Favalli","year":"2021","unstructured":"Favalli EG, Ingegnoli F, Cimaz R, Caporali R (2021) What is the true incidence of COVID-19 in patients with rheumatic diseases? Ann Rheum Dis 80(2):e18. https:\/\/doi.org\/10.1136\/annrheumdis-2020-217615","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"4987_CR18","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.semarthrit.2020.05.001","volume":"50","author":"X Michelena","year":"2020","unstructured":"Michelena X, Borrell H, L\u00f3pez-Corbeto M et al (2020) Incidence of COVID-19 in a cohort of adult and pediatric patients with rheumatic diseases treated with targeted biologic and synthetic disease-modifying antirheumatic drugs. Semin Arthritis Rheum 50(4):564\u2013570. https:\/\/doi.org\/10.1016\/j.semarthrit.2020.05.001","journal-title":"Semin Arthritis Rheum"},{"issue":"5","key":"4987_CR19","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.jbspin.2020.05.003","volume":"87","author":"L Quartuccio","year":"2020","unstructured":"Quartuccio L, Valent F, Pasut E, Tascini C, De Vita S (2020) Prevalence of COVID-19 among patients with chronic inflammatory rheumatic diseases treated with biologic agents or small molecules: a population-based study in the first two months of COVID-19 outbreak in Italy. Joint Bone Spine 87(5):439\u2013443. https:\/\/doi.org\/10.1016\/j.jbspin.2020.05.003","journal-title":"Joint Bone Spine"},{"issue":"10","key":"4987_CR20","doi-asserted-by":"publisher","first-page":"e583","DOI":"10.1016\/S2665-9913(20)30286-1","volume":"2","author":"F Hooijberg","year":"2020","unstructured":"Hooijberg F, Boekel L, Vogelzang EH, Leeuw M, Boers M, van Vollenhoven R, Lems WF, Nurmohamed MT, Wolbink G (2020) Patients with rheumatic diseases adhere to COVID-19 isolation measures more strictly than the general population. Lancet Rheumatol 2(10):e583\u2013e585. https:\/\/doi.org\/10.1016\/S2665-9913(20)30286-1","journal-title":"Lancet Rheumatol"},{"issue":"5","key":"4987_CR21","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1007\/s00296-021-04803-9","volume":"41","author":"Q Wang","year":"2021","unstructured":"Wang Q, Liu J, Shao R, Han X, Su C, Lu W (2021) Risk and clinical outcomes of COVID-19 in patients with rheumatic diseases compared with the general population: a systematic review and meta-analysis. Rheumatol Int 41(5):851\u2013861. https:\/\/doi.org\/10.1007\/s00296-021-04803-9","journal-title":"Rheumatol Int"},{"issue":"4","key":"4987_CR22","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1136\/annrheumdis-2020-218697","volume":"80","author":"C Dejaco","year":"2021","unstructured":"Dejaco C, Alunno A, Bijlsma JW, Boonen A, Combe B, Finckh A, Machado PM, Padjen I, Sivera F, Stamm TA, Buttgereit F (2021) Influence of COVID-19 pandemic on decisions for the management of people with inflammatory rheumatic and musculoskeletal diseases: a survey among EULAR countries. Ann Rheum Dis 80(4):518\u2013526. https:\/\/doi.org\/10.1136\/annrheumdis-2020-218697","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"4987_CR23","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1136\/annrheumdis-2020-218705","volume":"80","author":"A Ciurea","year":"2021","unstructured":"Ciurea A, Papagiannoulis E, B\u00fcrki K, Von Loga I, Micheroli R, M\u00f6ller B, Rubbert-Roth A, Andor M, Br\u00e4m R, M\u00fcller A, Dan D (2021) Impact of the COVID-19 pandemic on the disease course of patients with inflammatory rheumatic diseases: results from the Swiss Clinical Quality Management cohort. Ann Rheum Dis 80(2):238\u2013241. https:\/\/doi.org\/10.1136\/annrheumdis-2020-218705","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"4987_CR24","doi-asserted-by":"publisher","first-page":"454","DOI":"10.3899\/jrheum.200989","volume":"48","author":"AS Faye","year":"2021","unstructured":"Faye AS, Lee KE, Laszkowska M, Kim J, Blackett JW, McKenney AS, Krigel A, Giles JT, Wang R, Bernstein EJ, Green PH (2021) Risk of adverse outcomes in hospitalized patients with autoimmune disease and COVID-19: a matched cohort study from New York City. J Rheumatol 48(3):454\u2013462. https:\/\/doi.org\/10.3899\/jrheum.200989","journal-title":"J Rheumatol"},{"issue":"4","key":"4987_CR25","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1136\/annrheumdis-2020-218310","volume":"80","author":"FAI2R\/SFR\/SNFMI\/SOFREMIP\/CRI\/IMMEDIATE consortium and contributors","year":"2021","unstructured":"FAI2R\/SFR\/SNFMI\/SOFREMIP\/CRI\/IMMEDIATE consortium and contributors (2021) Severity of COVID-19 and survival in patients with rheumatic and inflammatory diseases: data from the French RMD COVID-19 cohort of 694 patients. Ann Rheum Dis 80(4):527\u2013538. https:\/\/doi.org\/10.1136\/annrheumdis-2020-218310","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"4987_CR26","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1136\/annrheumdis-2020-218296","volume":"79","author":"JL Pablos","year":"2020","unstructured":"Pablos JL, Galindo M, Carmona L, Lled\u00f3 A, Retuerto M, Blanco R, Gonzalez-Gay MA, Martinez-Lopez D, Castrej\u00f3n I, Alvaro-Gracia JM, Fern\u00e1ndez DF (2020) Clinical outcomes of hospitalised patients with COVID-19 and chronic inflammatory and autoimmune rheumatic diseases: a multicentric matched cohort study. Ann Rheum Dis 79(12):1544\u20131549. https:\/\/doi.org\/10.1136\/annrheumdis-2020-218296","journal-title":"Ann Rheum Dis"},{"key":"4987_CR27","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-219498","author":"A Strangfeld","year":"2021","unstructured":"Strangfeld A, Sch\u00e4fer M, Gianfrancesco MA, Lawson-Tovey S, Liew JW, Ljung L, Mateus EF, Richez C, Santos MJ, Schmajuk G, Scir\u00e8 CA (2021) Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry. Ann Rheum Dis. https:\/\/doi.org\/10.1136\/annrheumdis-2020-219498","journal-title":"Ann Rheum Dis"},{"key":"4987_CR28","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1007\/s10067-020-05073-9","volume":"39","author":"DP Misra","year":"2020","unstructured":"Misra DP, Agarwal V, Gasparyan AY, Zimba O (2020) Rheumatologists\u2019 perspective on coronavirus disease 19 (COVID-19) and potential therapeutic targets. Clin Rheumatol 39:2055\u20132062. https:\/\/doi.org\/10.1007\/s10067-020-05073-9","journal-title":"Clin Rheumatol"},{"issue":"5","key":"4987_CR29","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1016\/j.semarthrit.2020.06.012","volume":"50","author":"GA Ramirez","year":"2020","unstructured":"Ramirez GA, Gerosa M, Beretta L, Bellocchi C, Argolini LM, Moroni L, Della Torre E, Artusi C, Nicolosi S, Caporali R, Bozzolo EP (2020) COVID-19 in systemic lupus erythematosus: data from a survey on 417 patients. Semin Arthritis Rheum 50(5):1150\u20131157. https:\/\/doi.org\/10.1016\/j.semarthrit.2020.06.012","journal-title":"Semin Arthritis Rheum"},{"key":"4987_CR30","doi-asserted-by":"publisher","first-page":"2811","DOI":"10.1007\/s10067-020-05310-1","volume":"39","author":"EM Cardoso","year":"2020","unstructured":"Cardoso EM, Hundal J, Feterman D, Magaldi J (2020) Concomitant new diagnosis of systemic lupus erythematosus and COVID-19 with possible antiphospholipid syndrome. Just a coincidence? A case report and review of intertwining pathophysiology. Clin Rheumatol 39:2811\u20132815. https:\/\/doi.org\/10.1007\/s10067-020-05310-1","journal-title":"Clin Rheumatol"},{"key":"4987_CR31","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1007\/s00296-021-04794-7","volume":"41","author":"AE Gracia-Ramos","year":"2021","unstructured":"Gracia-Ramos AE, Saavedra-Salinas M\u00c1 (2021) Can the SARS-CoV-2 infection trigger systemic lupus erythematosus? A case-based review. Rheumatol Int 41:799\u2013809. https:\/\/doi.org\/10.1007\/s00296-021-04794-7","journal-title":"Rheumatol Int"},{"issue":"10","key":"4987_CR32","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1007\/s00296-020-04639-9","volume":"40","author":"S Shah","year":"2020","unstructured":"Shah S, Danda D, Kavadichanda C, Das S, Adarsh MB, Negi VS (2020) Autoimmune and rheumatic musculoskeletal diseases as a consequence of SARS-CoV-2 infection and its treatment. Rheumatol Int 40(10):1539\u20131554. https:\/\/doi.org\/10.1007\/s00296-020-04639-9","journal-title":"Rheumatol Int"},{"key":"4987_CR33","doi-asserted-by":"publisher","DOI":"10.1590\/0037-8682-0450-2020","author":"RZ Mariano","year":"2020","unstructured":"Mariano RZ, Rio AP, Reis F (2020) Covid-19 overlapping with systemic sclerosis. Rev Soc Bras Med Tro. https:\/\/doi.org\/10.1590\/0037-8682-0450-2020","journal-title":"Rev Soc Bras Med Tro"},{"issue":"3","key":"4987_CR34","doi-asserted-by":"publisher","first-page":"e166","DOI":"10.1016\/S2665-9913(21)00007-2","volume":"3","author":"C Ferri","year":"2021","unstructured":"Ferri C, Giuggioli D, Raimondo V, Dagna L, Riccieri V, Zanatta E, Guiducci S, Tavoni A, Foti R, Cuomo G, De Angelis R (2021) COVID-19 and systemic sclerosis: clinicopathological implications from Italian nationwide survey study. Lancet Rheumatol 3(3):e166\u2013e168. https:\/\/doi.org\/10.1016\/S2665-9913(21)00007-2","journal-title":"Lancet Rheumatol"},{"key":"4987_CR35","doi-asserted-by":"publisher","first-page":"S724","DOI":"10.1136\/annrheumdis-2020-217407","volume":"79","author":"M Matucci-Cerinic","year":"2020","unstructured":"Matucci-Cerinic M, Bruni C, Allanore Y et al (2020) Systemic sclerosis and the COVID-19 pandemic: world scleroderma Foundation preliminary advice for patient management. Ann Rheum 79:S724\u2013S726. https:\/\/doi.org\/10.1136\/annrheumdis-2020-217407","journal-title":"Ann Rheum"},{"issue":"3","key":"4987_CR36","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/S2665-9913(20)30420-3","volume":"3","author":"D McGonagle","year":"2021","unstructured":"McGonagle D, Bridgewood C, Ramanan AV, Meaney JF, Watad A (2021) COVID-19 vasculitis and novel vasculitis mimics. Lancet Rheumatol 3(3):224\u2013233. https:\/\/doi.org\/10.1016\/S2665-9913(20)30420-3","journal-title":"Lancet Rheumatol"},{"key":"4987_CR37","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1007\/s00296-021-04896-2","volume":"41","author":"B \u00d6zdemir","year":"2021","unstructured":"\u00d6zdemir B, Erden A, G\u00fcven SC, Armagan B, Apaydin H, Karakas \u00d6, Akdag AG, Ates \u0130, Kucuksahin O, Omma A (2021) COVID-19 and eosinophilic granulomatosis with polyangiitis or COVID-19 mimicking eosinophilic granulomatosis with polyangiitis? Rheumatol Int 41:1515\u20131521. https:\/\/doi.org\/10.1007\/s00296-021-04896-2","journal-title":"Rheumatol Int"},{"issue":"1","key":"4987_CR38","doi-asserted-by":"publisher","first-page":"79","DOI":"10.7861\/clinmed.2020-0793","volume":"21","author":"Q Qurratulain","year":"2021","unstructured":"Qurratulain Q, Ahmed A, Jones Q (2021) Lesson of the month: Severe granulomatosis with polyangiitis (GPA): a diagnostic challenge during the COVID-19 pandemic. Clin Med (Lond) 21(1):79\u201380. https:\/\/doi.org\/10.7861\/clinmed.2020-0793","journal-title":"Clin Med (Lond)"},{"issue":"3","key":"4987_CR39","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1002\/jmv.26587","volume":"93","author":"S Halpin","year":"2021","unstructured":"Halpin S, O\u2019Connor R, Sivan M (2021) Long COVID and chronic COVID syndromes. J Med Virol 93(3):1242\u20131243. https:\/\/doi.org\/10.1002\/jmv.26587","journal-title":"J Med Virol"},{"issue":"3278","key":"4987_CR40","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/S0262-4079(20)30746-6","volume":"246","author":"C Wilson","year":"2020","unstructured":"Wilson C (2020) Concern coronavirus may trigger post-viral fatigue syndromes. New Sci 246(3278):10\u201311. https:\/\/doi.org\/10.1016\/S0262-4079(20)30746-6","journal-title":"New Sci"},{"key":"4987_CR41","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1038\/s41584-020-0448-7","volume":"16","author":"C Galeotti","year":"2020","unstructured":"Galeotti C, Bayry J (2020) Autoimmune and inflammatory diseases following COVID-19. Nat Rev Rheumatol 16:413\u2013414. https:\/\/doi.org\/10.1038\/s41584-020-0448-7","journal-title":"Nat Rev Rheumatol"},{"key":"4987_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.mehy.2021.110538","volume":"149","author":"J Jacobs","year":"2021","unstructured":"Jacobs J (2021) Persistent SARS-2 infections contribute to long COVID-19. Med Hypotheses 149:110538. https:\/\/doi.org\/10.1016\/j.mehy.2021.110538","journal-title":"Med Hypotheses"},{"key":"4987_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2021.102644","volume":"120","author":"JY Wang","year":"2021","unstructured":"Wang JY, Zhang W, Roehrl MW, Roehrl VB, Roehrl MH (2021) An autoantigen profile of human A549 lung cells reveals viral and host etiologic molecular attributes of autoimmunity in COVID-19. J Autoimmun 120:102644. https:\/\/doi.org\/10.1016\/j.jaut.2021.102644","journal-title":"J Autoimmun"},{"issue":"18","key":"4987_CR44","doi-asserted-by":"publisher","first-page":"9695","DOI":"10.26355\/eurrev_202009_23060","volume":"24","author":"R Bonometti","year":"2020","unstructured":"Bonometti R, Sacchi M, Stobbione P et al (2020) The first case of systemic lupus erythematosus (SLE) triggered by COVID-19 infection. Eur Rev Med Pharmacol Sci 24(18):9695\u20139697. https:\/\/doi.org\/10.26355\/eurrev_202009_23060","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"4987_CR45","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m2094","volume":"369","author":"J Toubiana","year":"2020","unstructured":"Toubiana J, Poirault C, Corsia A, Bajolle F, Fourgeaud J, Angoulvant F, Debray A, Basmaci R, Salvador E, Biscardi S, Frange P (2020) Kawasaki-like multisystem inflammatory syndrome in children during the covid-19 pandemic in Paris, France: prospective observational study. BMJ 369:m2094. https:\/\/doi.org\/10.1136\/bmj.m2094","journal-title":"BMJ"},{"issue":"3","key":"4987_CR46","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2021-242142","volume":"14","author":"V Selvaraj","year":"2021","unstructured":"Selvaraj V, Moustafa A, Dapaah-Afriyie K, Birkenbach MP (2021) COVID-19-induced granulomatosis with polyangiitis. BMJ Case Reports CP 14(3):e242142. https:\/\/doi.org\/10.1136\/bcr-2021-242142","journal-title":"BMJ Case Reports CP"},{"issue":"7","key":"4987_CR47","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1002\/art.41734","volume":"73","author":"JR Curtis","year":"2021","unstructured":"Curtis JR, Johnson SR, Anthony DD, Arasaratnam RJ, Baden LR, Bass AR et al (2021) American College of Rheumatology Guidance for COVID-19 vaccination in patients with rheumatic and musculoskeletal diseases\u2014version 1. Arthritis Rheumatol 73(7):1093\u20131107. https:\/\/doi.org\/10.1002\/art.41734","journal-title":"Arthritis Rheumatol"},{"issue":"12","key":"4987_CR48","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2021.36.e95","volume":"36","author":"JK Park","year":"2021","unstructured":"Park JK, Lee EB, Shin K, Sung YK, Kim TH, Kwon SR, Lee MS, Hong SJ, Choi BY, Lee SS, Back HJ (2021) COVID-19 vaccination in patients with autoimmune inflammatory rheumatic diseases: clinical guidance of the Korean College of Rheumatology. J Korean Med Sci 36(12):e95. https:\/\/doi.org\/10.3346\/jkms.2021.36.e95","journal-title":"J Korean Med Sci"},{"issue":"6","key":"4987_CR49","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1111\/1756-185X.14107","volume":"24","author":"A Santosa","year":"2021","unstructured":"Santosa A, Xu C, Arkachaisri T, Kong KO, Lateef A, Lee TH, Leong KH, Low AHL, Sriranganathan MK, Tan TC, Teng GG (2021) Recommendations for COVID-19 vaccination in people with rheumatic disease: developed by the Singapore Chapter of Rheumatologists. Int J Rheum Dis 24(6):746\u2013757. https:\/\/doi.org\/10.1111\/1756-185X.14107","journal-title":"Int J Rheum Dis"},{"issue":"4","key":"4987_CR50","doi-asserted-by":"publisher","first-page":"430","DOI":"10.31138\/mjr.31.4.430","volume":"31","author":"Society, The Greek Rheumatology, and Professional Association of Rheumatologists","year":"2020","unstructured":"Society, The Greek Rheumatology, and Professional Association of Rheumatologists (2020) Vaccination against SARS-CoV-2 in immunosuppressed patients with rheumatic diseases: position statement of the Greek Rheumatology Society. Mediterr J Rheumatol 31(4):430\u2013432. https:\/\/doi.org\/10.31138\/mjr.31.4.430","journal-title":"Mediterr J Rheumatol"},{"key":"4987_CR51","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.3389\/fimmu.2021.656362","volume":"12","author":"F Ferretti","year":"2021","unstructured":"Ferretti F, Cannatelli R, Benucci M, Carmagnola S, Clementi E, Danelli P, Dilillo D, Fiorina P, Galli M, Gallieni M, Genovese G (2021) How to manage COVID-19 vaccination in immune-mediated inflammatory diseases: an expert opinion by IMIDs Study Group. Front Immunol 12:1206. https:\/\/doi.org\/10.3389\/fimmu.2021.656362","journal-title":"Front Immunol"},{"issue":"1","key":"4987_CR52","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2021-000479","volume":"8","author":"W Tang","year":"2021","unstructured":"Tang W, Askanase AD, Khalili L, Merrill JT (2021) SARS-CoV-2 vaccines in patients with SLE. Lupus Sci Med 8(1):e000479. https:\/\/doi.org\/10.1136\/lupus-2021-000479","journal-title":"Lupus Sci Med"},{"issue":"5","key":"4987_CR53","doi-asserted-by":"publisher","first-page":"435","DOI":"10.3390\/vaccines9050435","volume":"9","author":"A Watad","year":"2021","unstructured":"Watad A, De Marco G, Mahajna H, Druyan A, Entity M, Hijazi N, Haddad A, Elias M, Zisman D, Naffaa ME, Brodavka M (2021) Immune-mediated disease flares or new-onset disease in 27 subjects following mRNA\/DNA SARS-CoV-2 vaccination. Vaccines 9(5):435. https:\/\/doi.org\/10.3390\/vaccines9050435","journal-title":"Vaccines"},{"issue":"7","key":"4987_CR54","doi-asserted-by":"publisher","first-page":"e469","DOI":"10.1016\/S2665-9913(21)00108-9","volume":"3","author":"KA Terracina","year":"2021","unstructured":"Terracina KA, Tan FK (2021) Flare of rheumatoid arthritis after COVID-19 vaccination. Lancet Rheumatol 3(7):e469\u2013e470. https:\/\/doi.org\/10.1016\/S2665-9913(21)00108-9","journal-title":"Lancet Rheumatol"},{"key":"4987_CR55","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2021.1920274","author":"QJ An","year":"2021","unstructured":"An QJ, Qin DA, Pei JX (2021) Reactive arthritis after COVID-19 vaccination. Hum Vaccin Immunother. https:\/\/doi.org\/10.1080\/21645515.2021.1920274","journal-title":"Hum Vaccin Immunother"},{"issue":"5","key":"4987_CR56","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2021-243066","volume":"14","author":"RC Flowers","year":"2021","unstructured":"Flowers RC, Rivera Rodriguez B, Corbitt K (2021) Streptococcus Gordonii septic arthritis of the glenohumeral joint following deltoid intramuscular vaccination. BMJ Case Rep 14(5):e243066. https:\/\/doi.org\/10.1136\/bcr-2021-243066","journal-title":"BMJ Case Rep"},{"issue":"6","key":"4987_CR57","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1007\/s00296-021-04847-x","volume":"41","author":"SD Wade","year":"2021","unstructured":"Wade SD, Kyttaris VC (2021) Rituximab-associated hypogammaglobulinemia in autoimmune rheumatic diseases: a single-center retrospective cohort study. Rheumatol Int 41(6):1115\u20131124. https:\/\/doi.org\/10.1007\/s00296-021-04847-x","journal-title":"Rheumatol Int"},{"key":"4987_CR58","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2021-220604","author":"R Spiera","year":"2021","unstructured":"Spiera R, Jinich S, Jannat-Khah D (2021) Rituximab, but not other antirheumatic therapies, is associated with impaired serological response to SARS- CoV-2 vaccination in patients with rheumatic diseases. Ann Rheum Dis. https:\/\/doi.org\/10.1136\/annrheumdis-2021-220604","journal-title":"Ann Rheum Dis"},{"key":"4987_CR59","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2021-220597","author":"RH Haberman","year":"2021","unstructured":"Haberman RH, Herati R, Simon D, Samanovic M, Blank RB, Tuen M, Koralov S, Atreya R, Tascilar K, Allen J, Castillo R (2021) Methotrexate hampers immunogenicity to BNT162b2 mRNA COVID-19 vaccine in immune-mediated inflammatory disease. Ann Rheum Dis. https:\/\/doi.org\/10.1136\/annrheumdis-2021-220597","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"4987_CR60","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1007\/s00296-021-04841-3","volume":"41","author":"B Yurttas","year":"2021","unstructured":"Yurttas B, Poyraz BC, Sut N, Ozdede A, Oztas M, U\u011furlu S, Tabak F, Hamuryudan V, Seyahi E (2021) Willingness to get the COVID-19 vaccine among patients with rheumatic diseases, healthcare workers and general population in Turkey: a web-based survey. Rheumatol Int 41(6):1105\u20131114. https:\/\/doi.org\/10.1007\/s00296-021-04841-3","journal-title":"Rheumatol Int"},{"issue":"4","key":"4987_CR61","doi-asserted-by":"publisher","first-page":"e243","DOI":"10.1016\/S2665-9913(21)00039-4","volume":"3","author":"R Felten","year":"2021","unstructured":"Felten R, Dubois M, Ugarte-Gil MF, Chaudier A, Kawka L, Bergier H, Costecalde C, Pijnenburg L, Fort J, Chatelus E, Sordet C (2021) Vaccination against COVID-19: expectations and concerns of patients with autoimmune and rheumatic diseases. Lancet Rheumatol 3(4):e243\u2013e245. https:\/\/doi.org\/10.1016\/S2665-9913(21)00039-4","journal-title":"Lancet Rheumatol"},{"issue":"5","key":"4987_CR62","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1007\/s00296-021-04817-3","volume":"41","author":"GE Fragoulis","year":"2021","unstructured":"Fragoulis GE, Grigoropoulos I, Mavrea E, Arida A, Bournia VK, Evangelatos G, Fragiadaki K, Karamanakos A, Kravvariti E, Panopoulos S, Pappa M (2021) Increased influenza vaccination rates in patients with autoimmune rheumatic diseases during the Covid-19 pandemic: a cross-sectional study. Rheumatol Int 41(5):895\u2013902. https:\/\/doi.org\/10.1007\/s00296-021-04817-3","journal-title":"Rheumatol Int"},{"issue":"5","key":"4987_CR63","doi-asserted-by":"publisher","first-page":"427","DOI":"10.3390\/vaccines9050427","volume":"9","author":"C Zanettini","year":"2021","unstructured":"Zanettini C, Omar M, Dinalankara W, Imada EL, Colantuoni E, Parmigiani G, Marchionni L (2021) Influenza vaccination and covid-19 mortality in the USA: an ecological study. Vaccines 9(5):427. https:\/\/doi.org\/10.3390\/vaccines9050427","journal-title":"Vaccines"},{"issue":"7","key":"4987_CR64","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1177\/09612033211002270","volume":"30","author":"HT Smeele","year":"2021","unstructured":"Smeele HT, Perez-Garcia LF, Grimminck K, Schoenmakers S, Mulders AG, Dolhain RJ (2021) Systemic lupus erythematosus and COVID-19 during pregnancy. Lupus 30(7):1188\u20131191. https:\/\/doi.org\/10.1177\/09612033211002270","journal-title":"Lupus"},{"issue":"11","key":"4987_CR65","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1007\/s00296-020-04698-y","volume":"40","author":"VV Boyadzhieva","year":"2020","unstructured":"Boyadzhieva VV, Stoilov NR, Stoilov RM (2020) Coronavirus disease 2019 (COVID-19) during pregnancy in patients with rheumatic diseases. Rheumatol Int 40(11):1753\u20131762. https:\/\/doi.org\/10.1007\/s00296-020-04698-y","journal-title":"Rheumatol Int"},{"issue":"2","key":"4987_CR66","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1002\/ijgo.13255","volume":"150","author":"M Scioscia","year":"2020","unstructured":"Scioscia M, Praino E, Scioscia C (2020) Rheumatic diseases during pregnancy and SARS-CoV-2: an appeal for medication adherence. Int J Gynecol Obstet 150(2):269\u2013270. https:\/\/doi.org\/10.1002\/ijgo.13255","journal-title":"Int J Gynecol Obstet"},{"key":"4987_CR67","doi-asserted-by":"publisher","DOI":"10.1016\/j.jri.2020.103168","volume":"141","author":"J Kwak-Kim","year":"2020","unstructured":"Kwak-Kim J, Ota K, Sung N, Huang C, Alsubki L, Lee S, Han JW, Han A, Yang X, Saab W, Derbala Y (2020) COVID-19 and immunomodulation treatment for women with reproductive failures. J Reprod Immunol 141:103168. https:\/\/doi.org\/10.1016\/j.jri.2020.103168","journal-title":"J Reprod Immunol"},{"issue":"13","key":"4987_CR68","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1177\/0961203320952848","volume":"29","author":"VL Ramoni","year":"2020","unstructured":"Ramoni VL, Xoxi B, Beneventi F, Bellingeri C, Montecucco C, Spinillo A (2020) Efficacy of a screening strategy for the detection of rheumatic diseases in early pregnancy during COVID-19 pandemic. Lupus 29(13):1821\u20131823. https:\/\/doi.org\/10.1177\/0961203320952848","journal-title":"Lupus"},{"issue":"1","key":"4987_CR69","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s00296-020-04737-8","volume":"41","author":"R Naveen","year":"2021","unstructured":"Naveen R, Sundaram TG, Agarwal V, Gupta L (2021) Teleconsultation experience with the idiopathic inflammatory myopathies: a prospective observational cohort study during the COVID-19 pandemic. Rheumatol Int 41(1):67\u201376. https:\/\/doi.org\/10.1007\/s00296-020-04737-8","journal-title":"Rheumatol Int"},{"issue":"3","key":"4987_CR70","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1007\/s00296-020-04771-6","volume":"41","author":"WH Bos","year":"2021","unstructured":"Bos WH, van Tubergen A, Vonkeman HE (2021) Telemedicine for patients with rheumatic and musculoskeletal diseases during the COVID-19 pandemic; a positive experience in the Netherlands. Rheumatol Int 41(3):565\u2013573. https:\/\/doi.org\/10.1007\/s00296-020-04771-6","journal-title":"Rheumatol Int"},{"issue":"6","key":"4987_CR71","doi-asserted-by":"publisher","first-page":"e97","DOI":"10.1136\/annrheumdis-2020-218220","volume":"80","author":"H So","year":"2021","unstructured":"So H, Szeto CC, Tam LS (2021) Patient acceptance of using telemedicine for follow-up of lupus nephritis in the COVID-19 outbreak. Ann Rheum Dis 80(6):e97\u2013e97. https:\/\/doi.org\/10.1136\/annrheumdis-2020-218220","journal-title":"Ann Rheum Dis"},{"key":"4987_CR72","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2020-001548","volume":"7","author":"A Kernder","year":"2021","unstructured":"Kernder A, Morf H, Klemm P et al (2021) Digital rheumatology in the era of COVID-19: results of a national patient and physician survey. RMD Open 7:e001548. https:\/\/doi.org\/10.1136\/rmdopen-2020-001548","journal-title":"RMD Open"},{"issue":"11","key":"4987_CR73","doi-asserted-by":"publisher","first-page":"3191","DOI":"10.1007\/s10067-020-05338-3","volume":"39","author":"A Howren","year":"2020","unstructured":"Howren A, Avi\u00f1a-Zubieta JA, Rebi\u0107 N, Dau H, Gastonguay L, Shojania K, Davidson E, De Vera MA (2020) Virtual rheumatology appointments during the COVID-19 pandemic: an international survey of perspectives of patients with rheumatic diseases. Clin Rheumatol 39(11):3191\u20133193. https:\/\/doi.org\/10.1007\/s10067-020-05338-3","journal-title":"Clin Rheumatol"},{"issue":"4","key":"4987_CR74","doi-asserted-by":"publisher","first-page":"e50","DOI":"10.1136\/annrheumdis-2020-218008","volume":"80","author":"C L\u00f3pez-Medina","year":"2021","unstructured":"L\u00f3pez-Medina C, Escudero A, Collantes-Estevez E (2021) COVID-19 pandemic: an opportunity to assess the utility of telemedicine in patients with rheumatic diseases. Ann Rheum Dis 80(4):e50\u2013e50. https:\/\/doi.org\/10.1136\/annrheumdis-2020-218008","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"4987_CR75","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1007\/s00296-021-04863-x","volume":"41","author":"M Chevallard","year":"2021","unstructured":"Chevallard M, Belloli L, Ughi N, Adinolfi A, Casu C, Di Cicco M, Filippini DA, Muscar\u00e0 M, Schito E, Verduci E, Gentile MG (2021) Use of telemedicine during the COVID-19 pandemic in patients with inflammatory arthritis: a retrospective study on feasibility and impact on patient-reported outcomes in a real-life setting. Rheumatol Int 41(7):1253\u20131261. https:\/\/doi.org\/10.1007\/s00296-021-04863-x","journal-title":"Rheumatol Int"},{"key":"4987_CR76","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s13047-020-00441-9","volume":"14","author":"JL Palmer","year":"2021","unstructured":"Palmer JL, Siddle HJ, Redmond AC, Alcacer-Pitarch B (2021) Implementation of podiatry telephone appointments for people with rheumatic and musculoskeletal diseases. J Foot Ankle Res 14:4. https:\/\/doi.org\/10.1186\/s13047-020-00441-9","journal-title":"J Foot Ankle Res"},{"issue":"6","key":"4987_CR77","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1007\/s00296-021-04853-z","volume":"41","author":"H Morf","year":"2021","unstructured":"Morf H, Krusche M, Knitza J (2021) Patient self-sampling: a cornerstone of future rheumatology care? Rheumatol Int 41(6):1187\u20131188. https:\/\/doi.org\/10.1007\/s00296-021-04853-z","journal-title":"Rheumatol Int"},{"key":"4987_CR78","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.jpba.2017.03.047","volume":"140","author":"Y Qu","year":"2017","unstructured":"Qu Y, Brady K, Apilado R et al (2017) Capillary blood collected on volumetric absorptive microsampling (VAMS) device for monitoring hydroxychloroquine in rheumatoid arthritis patients. J Pharm Biomed Anal 140:334\u2013341. https:\/\/doi.org\/10.1016\/j.jpba.2017.03.047","journal-title":"J Pharm Biomed Anal"},{"key":"4987_CR79","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1007\/s00296-020-04769-0","volume":"41","author":"S Bilal","year":"2021","unstructured":"Bilal S, Shanmugam VK (2021) Enhancing rheumatology education during the COVID-19 pandemic. Rheumatol Int 41:503\u2013508. https:\/\/doi.org\/10.1007\/s00296-020-04769-0","journal-title":"Rheumatol Int"},{"key":"4987_CR80","doi-asserted-by":"publisher","first-page":"3535","DOI":"10.1007\/s10067-020-05449-x","volume":"39","author":"AB Dua","year":"2020","unstructured":"Dua AB, Kilian A, Grainger R, Fantus SA, Wallace ZS, Buttgereit F, Jonas BL (2020) Challenges, collaboration, and innovation in rheumatology education during the COVID-19 pandemic: leveraging new ways to teach. Clin Rheumatol 39:3535\u20133541. https:\/\/doi.org\/10.1007\/s10067-020-05449-x","journal-title":"Clin Rheumatol"},{"key":"4987_CR81","doi-asserted-by":"publisher","first-page":"3215","DOI":"10.1007\/s10067-020-05405-9","volume":"39","author":"S Ahmed","year":"2020","unstructured":"Ahmed S, Zimba O, Gasparyan AY (2020) Moving towards online rheumatology education in the era of COVID-19. Clin Rheumatol 39:3215\u20133222. https:\/\/doi.org\/10.1007\/s10067-020-05405-9","journal-title":"Clin Rheumatol"},{"issue":"12","key":"4987_CR82","doi-asserted-by":"publisher","first-page":"3533","DOI":"10.1007\/s10067-020-05468-8","volume":"39","author":"S Ahmed","year":"2020","unstructured":"Ahmed S, Zimba O, Gasparyan AY (2020) Diversifying online rheumatology education options in the era of COVID-19. Clin Rheumatol 39(12):3533\u20133534. https:\/\/doi.org\/10.1007\/s10067-020-05468-8","journal-title":"Clin Rheumatol"},{"key":"4987_CR83","doi-asserted-by":"publisher","first-page":"102780","DOI":"10.1016\/j.nepr.2020.102780","volume":"44","author":"SCK Shaw","year":"2020","unstructured":"Shaw SCK (2020) Hopelessness, helplessness, and resilience: the importance of safeguarding our trainees\u2019 mental wellbeing during the COVID-19 pandemic. Nurse Educ Pract 44:102780\u2013102780","journal-title":"Nurse Educ Pract"},{"issue":"2","key":"4987_CR84","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s00296-019-04504-4","volume":"40","author":"B Doskaliuk","year":"2020","unstructured":"Doskaliuk B, Zimba O, Yatsyshyn R, Kovalenko V (2020) Rheumatology in Ukraine. Rheumatol Int 40(2):175\u2013182. https:\/\/doi.org\/10.1007\/s00296-019-04504-4","journal-title":"Rheumatol Int"},{"issue":"2","key":"4987_CR85","doi-asserted-by":"publisher","first-page":"e001183","DOI":"10.1136\/rmdopen-2020-001183","volume":"6","author":"A Najm","year":"2020","unstructured":"Najm A, Alunno A, Sivera F, Ramiro S, Haines C (2020) Working Group on Training in Rheumatology across Europe. Strategies for the assessment of competences during rheumatology training across Europe: results of a qualitative study. RMD Open 6(2):e001183. https:\/\/doi.org\/10.1136\/rmdopen-2020-001183","journal-title":"RMD Open"},{"issue":"4","key":"4987_CR86","doi-asserted-by":"publisher","first-page":"e60","DOI":"10.1136\/annrheumdis-2020-217935","volume":"80","author":"GE Fragoulis","year":"2020","unstructured":"Fragoulis GE, Evangelatos G, Arida A et al (2020) Treatment adherence of patients with systemic rheumatic diseases in COVID-19 pandemic. Ann Rheum Dis 80(4):e60\u2013e60. https:\/\/doi.org\/10.1136\/annrheumdis-2020-217935","journal-title":"Ann Rheum Dis"},{"key":"4987_CR87","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-218756","author":"A Khabbazi","year":"2020","unstructured":"Khabbazi A, Kavandi H, Paribanaem R et al (2020) Adherence to medication in patients with rheumatic diseases during COVID-19 pandemic. Ann Rheum Dis. https:\/\/doi.org\/10.1136\/annrheumdis-2020-218756","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"4987_CR88","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1002\/acr2.11148","volume":"2","author":"K Michaud","year":"2020","unstructured":"Michaud K, Wipfler K, Shaw Y, Simon TA, Cornish A, England BR, Ogdie A, Katz P (2020) Experiences of patients with rheumatic diseases in the United States during early days of the COVID-19 pandemic. ACR Open Rheumatol 2(6):335\u2013343. https:\/\/doi.org\/10.1002\/acr2.11148","journal-title":"ACR Open Rheumatol"},{"issue":"6","key":"4987_CR89","doi-asserted-by":"publisher","first-page":"e85","DOI":"10.1136\/annrheumdis-2020-218198","volume":"80","author":"RA Pineda-Sic","year":"2021","unstructured":"Pineda-Sic RA, Galarza-Delgado DA, Serna-Pe\u00f1a G, Castillo-Torres SA, Flores-Alvarado DE, Esquivel-Valerio JA, Hern\u00e1ndez-Galarza IDJ (2021) Treatment adherence behaviours in rheumatic diseases during COVID-19 pandemic: a Latin American experience. Ann Rheum Dis 80(6):e85\u2013e85. https:\/\/doi.org\/10.1136\/annrheumdis-2020-218198","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"4987_CR90","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1007\/s00296-021-04790-x","volume":"41","author":"G Durcan","year":"2021","unstructured":"Durcan G, Barut K, Haslak F, Doktur H, Yildiz M, Adrovic A, Sahin S, Kasapcopur O (2021) Psychosocial and clinical effects of the COVID-19 pandemic in patients with childhood rheumatic diseases and their parents. Rheumatol Int 41(3):575\u2013583. https:\/\/doi.org\/10.1007\/s00296-021-04790-x","journal-title":"Rheumatol Int"},{"key":"4987_CR91","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1007\/s00296-021-04829-z","volume":"41","author":"A Bhatia","year":"2021","unstructured":"Bhatia A, Manish KC, Gupta L (2021) Increased risk of mental health disorders in patients with RA during the COVID-19 pandemic: a possible surge and solutions. Rheumatol Int 41:843\u2013850. https:\/\/doi.org\/10.1007\/s00296-021-04829-z","journal-title":"Rheumatol Int"},{"key":"4987_CR92","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1186\/s12891-016-1011-1","volume":"17","author":"F Matcham","year":"2016","unstructured":"Matcham F, Ali S, Irving K et al (2016) Are depression and anxiety associated with disease activity in rheumatoid arthritis? A prospective study BMC prospective study. BMC Musculoskelet Disord 17:155. https:\/\/doi.org\/10.1186\/s12891-016-1011-1","journal-title":"BMC Musculoskelet Disord"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-021-04987-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-021-04987-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-021-04987-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,26]],"date-time":"2021-10-26T10:29:19Z","timestamp":1635244159000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00296-021-04987-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,1]]},"references-count":92,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["4987"],"URL":"https:\/\/doi.org\/10.1007\/s00296-021-04987-0","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,1]]},"assertion":[{"value":"10 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"No human participants\/animals were evaluated. These data are public. Therefore, there was no requirement for ethics committee approval.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical statement"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}